Holen Sie sich die Stockscreener-App
79.78
1.09%
0.86
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EW?
Forum
Prognose
Aktiensplit
Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten
Edwards Lifesciences Stock at $78: Here’s the Analysts’ Bull Case Scenario - TIKR.com
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing - The Motley Fool
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences - Yahoo Finance
First National Bank of Omaha Purchases New Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Alberta Investment Management Corp Buys Shares of 68,300 Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences advances smart surgery monitoring with completed SMART TRENDS study - MSN
Edwards Lifesciences Corporation $EW Holdings Raised by Vanguard Group Inc. - MarketBeat
Edwards Lifesciences (NYSE:EW) Trading Up 5.6%Here's Why - MarketBeat
Edwards Lifesciences Corp. Drops ‘Anti-Copycatting’ Policy Amid EU Probe - USA Herald
Edwards Sued In Chancery Over $300M Heart Valve Earn-Out - Law360
Edwards Lifesciences (EW) Rises as EU Antitrust Probe Ends - GuruFocus
Edwards Lifesciences (EW) Experiences Significant Price Surge - GuruFocus
European Commission ends Edwards antitrust probe after company withdraws anti-copycat policy - MassDevice
Edwards Lifesciences Corporation $EW Shares Sold by PNC Financial Services Group Inc. - MarketBeat
Edwards Lifesciences (NYSE:EW) Shows Institutional Concentration Trends Within The S&P 500 Today - Kalkine Media
Edwards Lifesciences Corporation (NYSE:EW) is a favorite amongst institutional investors who own 88% - Yahoo Finance
Tobam Has $5.22 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
EU Closes Antitrust Investigation Against US' Edwards Lifesciences - marketscreener.com
Edwards Lifesciences scraps anti-copycat policy, EU drops antitrust investigation - Reuters
Eu antitrust regulators close investigation into edwards lifesciences after company withdraws anti-copycat policy - marketscreener.com
Achy Breaky Heart: The FTC Blocks Edwards-JenaValve Aortic Device Deal - marketscreener.com
What’s the outlook for Edwards Lifesciences Corporation’s sectorQuarterly Growth Report & Fast Moving Stock Watchlists - mfd.ru
Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update - Finviz
Envestnet Asset Management Inc. Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences completes key study on SAPIEN XT THV - MSN
Is Edwards Lifesciences Corporation stock a smart retirement pickPortfolio Value Summary & Free Accurate Trade Setup Notifications - mfd.ru
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day - The AI Journal
Rhumbline Advisers Acquires 15,792 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How Investors Are Reacting To Edwards Lifesciences (EW) 2026 Guidance After Profit Squeeze In 2025 - Yahoo Finance
Halper Sadeh LLC Encourages Edwards Lifesciences - GlobeNewswire
Edwards Lifesciences Corporation $EW Shares Bought by Oppenheimer Asset Management Inc. - MarketBeat
Wells Fargo Raises Price Target for Edwards Lifesciences (EW) | - GuruFocus
Edwards Lifesciences Leans Into Growth After Strong Quarter - TipRanks
Edwards Lifesciences (EW): Truist Securities Maintains Hold Rati - GuruFocus
Edwards Lifesciences (EW) Analyst Ratings Update: Price Target L - GuruFocus
Edwards Lifesciences (NYSE:EW) Advances Structural Heart Solutions - Kalkine Media
Edwards Lifesciences Corp (NYSE:EW) Issues Upbeat Guidance - FXDailyReport.Com
Rothschild & Co Redburn Adjusts Edwards Lifesciences PT to $94 From $93, Maintains Buy Rating - marketscreener.com
Edwards Lifesciences 2026 Growth Targets Achievable, RBC Says - marketscreener.com
Piper Sandler Raises Price Target for Edwards Lifesciences (EW) to $100 | EW Stock News - GuruFocus
Edwards focuses on earlier TAVR adoption - MedTech Dive
Stifel reiterates Buy rating on Edwards Lifesciences stock at $110 target - Investing.com
Wells Fargo Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus
Truist Securities Adjusts Price Target on Edwards Lifesciences to $89 From $92, Maintains Hold Rating - marketscreener.com
Wells Fargo & Company Raises Edwards Lifesciences (NYSE:EW) Price Target to $100.00 - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Q4 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $100 From $96, Maintains Overweight Rating - marketscreener.com
Leerink Partners Adjusts Price Target on Edwards Lifesciences to $87 From $88, Maintains Market Perform Rating - marketscreener.com
Baird Adjusts Price Target on Edwards Lifesciences to $87 From $90, Maintains Neutral Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $95 From $108, Maintains Buy Rating - marketscreener.com
The Analyst Verdict: Edwards Lifesciences In The Eyes Of 21 Experts - Benzinga
BTIG Reiterates Buy Rating for Edwards Lifesciences (EW) | EW St - GuruFocus
Why The Narrative Around Edwards Lifesciences EW Is Shifting After 2026 Outlook And JenaValve Setback - Yahoo Finance
Edwards Lifesciences Corp (EW) Q4 2025 Earnings Call Highlights: Strong Sales Growth Amidst Strategic Investments - GuruFocus
Edwards Lifesciences Q4 Earnings Call Highlights - Yahoo Finance
Edwards Lifesciences earnings missed by $0.04, revenue topped estimates - Investing.com
Edwards Lifesciences (EW) Earnings Transcript - The Globe and Mail
Edwards Lifesciences misses EPS estimate by $0.04, surpasses revenue prediction - MassDevice
Edwards Lifesciences (NYSE:EW) Sees S&P 500 Trading Uptick, Guidance - Kalkine Media
Earnings call transcript: Edwards Lifesciences Q4 2025 misses EPS forecast By Investing.com - Investing.com Nigeria
Edwards Lifesciences (NYSE:EW) Updates Q1 2026 Earnings Guidance - MarketBeat
Earnings call transcript: Edwards Lifesciences Q4 2025 misses EPS forecast - Investing.com
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Edwards Lifesciences (NYSE:EW) Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
1.47%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):